SEC Form D private-offering filing

Aprea Therapeutics, Inc.

Name: Aprea Therapeutics, Inc. - new SEC Form D private-offering filing, Doylestown, PA
Published: 2025-12-29

A new SEC Form D private-offering notice from Doylestown, PA, a $5,783,766 filer-stated offering target in Biotech. The source filing is one click away.

Aprea Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage precision oncology biopharmaceutical company developing DNA damage response targeted small molecule cancer therapies, including WEE1 and ATR inhibitors.

Filed 2025-12-29Filed to raise $5,783,766First money in 2025-12-10Raised so far $3,055,822HQ (as filed) Doylestown, PASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified aprea.com↗Named in the filing 10 executives & directors

Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.